CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 75 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04191642
NCT04191642N/ACompleted

Correlation of NLRP3 With Cognitive Dysfunction Early After Heart Valve

General Hospital of Ningxia Medical University·observational·Posted Dec 10, 2019·Updated Sep 1, 2021

In Brief

An observational study for Inflammasomes and 3 related conditions. Completed, enrolled 75 participants across 1 site.

Detailed Summary

The investigators decided to assess the prognostic value of NLRP3 inflammasome level in early after heart valve replacement surgery and whether it was related to postoperative cognitive dysfunction. Study population included 90 subjects. Neuropsychological tests were administrated one day before surgery and seven days after surgery. Before induction of anesthesia, before the end of the operation, 7 days after the operation, peripheral venous blood was sampled to measure IL-1B, IL-18 and NLRP3 inflammatory protein expression in peripheral blood monocytes. Analyze the data and draw conclusions.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedDec 10, 2019
Enrollment StartApr 1, 2019
Primary CompletionJan 30, 2021
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.6 years ago